4-Butyryl-o-kresol | 52780-68-4

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 4-Butyryl-o-kresol
• 英文别名: 1-(4-hydroxy-3-methylphenyl)butan-1-one；1-(4-Hydroxy-3-methyl-phenyl)-butan-1-on
• CAS: 52780-68-4
• 化学式: C₁₁H₁₄O₂
• 分子量: 178.231
• InChiKey: NUBIDDDRLIKEEM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-Butyryl-o-kresol 在 盐酸羟胺 、 sodium acetate 、 potassium carbonate 、 caesium carbonate 作用下， 以 乙醇 、 水 、 N,N-二甲基甲酰胺 为溶剂， 反应 37.0h， 生成 (E)-ethyl 2-(2-methyl-4-(1-(((5-methyl-2-phenyloxazol-4-yl)methoxy)imino)butyl)phenoxy)acetate
  参考文献：
  名称：

  Effect of structurally constrained oxime–ether linker on PPAR subtype selectivity: Discovery of a novel and potent series of PPAR-pan agonists

  摘要：

  A novel series of thaizole and oxazole containing phenoxy acetic acid derivatives is reported as PPAR-pan agonists. Incorporation of structurally constrained oxime-ether based linker in the chemotype of a potent PPAR delta selective agonist GW-501516 was adapted as designing strategy. In vitro, selected test compounds 12a, 12c, 17a and 18a showed PPAR-pan agonists activities and among these four compounds tested, 12a emerged as highly potent and efficacious compound, while 17a exhibited moderate and balanced PPAR-pan agonistic activity. In vivo, selected test compounds 12a and 17a exhibited significant anti-hyperglycemic and anti-hyperlipidemic activities in relevant animal models. These results support our hypothesis that the introduction of structurally constrained oxime-ether linker between lipophilic tail and acidic head plays an important role in modulating subtype selectivity and subsequently led to the discovery of potent PPAR-pan agonists. (C) 2010 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2010.12.023
• 作为产物：
  描述：

  propanoate d'o-tolyle 在 aluminum (III) chloride 作用下， 反应 2.0h， 以27%的产率得到4-Butyryl-o-kresol
  参考文献：
  名称：

  Effect of structurally constrained oxime–ether linker on PPAR subtype selectivity: Discovery of a novel and potent series of PPAR-pan agonists

  摘要：

  A novel series of thaizole and oxazole containing phenoxy acetic acid derivatives is reported as PPAR-pan agonists. Incorporation of structurally constrained oxime-ether based linker in the chemotype of a potent PPAR delta selective agonist GW-501516 was adapted as designing strategy. In vitro, selected test compounds 12a, 12c, 17a and 18a showed PPAR-pan agonists activities and among these four compounds tested, 12a emerged as highly potent and efficacious compound, while 17a exhibited moderate and balanced PPAR-pan agonistic activity. In vivo, selected test compounds 12a and 17a exhibited significant anti-hyperglycemic and anti-hyperlipidemic activities in relevant animal models. These results support our hypothesis that the introduction of structurally constrained oxime-ether linker between lipophilic tail and acidic head plays an important role in modulating subtype selectivity and subsequently led to the discovery of potent PPAR-pan agonists. (C) 2010 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2010.12.023

文献信息

• 2-(Aminomethyl)phenols, a new class of saluretic agents. 1. Effects of nuclear substitution
  作者：G. E. Stokker、A. A. Deana、S. J. DeSolms、E. M. Schultz、R. L. Smith、E. J. Cragoe、J. E. Baer、C. T. Ludden、H. F. Russo

  DOI：10.1021/jm00186a024

  日期：1980.12

  A series of 2-(aminomethyl)phenols was synthesized and tested in rats and dogs for saluretic and diuretic activity. A number of these compounds exhibit a high order of activity on iv or po administration. The most active compounds belong to a subseries of 4-alkyl-6-halo derivatives of which 2, 2-(aminomethyl)-4-(1,1-dimethylethyl)-6-iodophenol, is the most active. Compound 2 also possesses significant

  合成了一系列2-（氨基甲基）酚，并在大鼠和狗中测试了其利尿和利尿活性。这些化合物中的许多在静脉内或口服给药时表现出高活性。活性最高的化合物属于4-烷基-6-卤代衍生物的子系列，其中2，2-（氨基甲基）-4-（1,1-二甲基乙基）-6-碘酚是最具活性的。化合物2还具有显着的降压活性，这是一种辅助药理参数，可将2与本系列制备的其他化合物区分开。此外，2显示局部利尿和抗炎活性。
• 2-(3,5-Dialkyl-4-hydroxyphenyl)indole derivatives
  申请人：TEIKOKU HORMONE MFG. CO., LTD.

  公开号：EP0173279A1

  公开（公告）日：1986-03-05

  A compound represented by the formula wherein R, represents a lower alkyl group; each of R2 and R3 represents an alkyl group having 1 to 3 carbon atoms; and each of R4, R5 and R6 represents a hydrogen atom, a halogen atom, a lower alkyl group, a lower alkoxy group, a lower alkanoyloxy group, an aralkyloxy group, a lower alkylthio group, a lower haloalkyl group, a hydroxyl group, a cyano group, a nitro group, an amino group, a mono- or di-(lower alkyl or aralkyl)amino group or a group of the formula or in which R7 represents a lower alkylene group having at least 2 carbon atoms, one of R8 and Rs represents a hydrogen atom or a lower alkyl group and the other represents a lower alkyl group, and R10 represents a hydrogen atom or a lower alkyl group; or any two of R4, R5 and R6 which are adjacent to each other, together, represent a lower alkylenedioxy group, and a salt thereof; and a process for production thereof. This compound has 5-lipoxygenase inhibiting activity and is useful as a medicament.

  一种由式表示的化合物 其中 R 代表低级烷基；R2 和 R3 分别代表具有 1 至 3 个碳原子的烷基；R4、R5 和 R6 分别代表氢原子、卤素原子、低级烷基、低级烷氧基、低级烷酰氧基、芳氧基、低级烷硫基、低级卤代烷基、羟基、氰基、硝基、氨基、一或二（低级烷基或芳烷基）氨基或式中的基团 或 其中 R7 代表至少有 2 个碳原子的低级亚烷基，R8 和 Rs 中的一个代表氢原子或低级烷基，另一个代表低级烷基，R10 代表氢原子或低级烷基；或相邻的 R4、R5 和 R6 中的任意两个共同代表低级亚烷基二氧基及其盐；以及其生产工艺。该化合物具有 5-脂氧合酶抑制活性，可用作药物。
• Booth, Brian L.; Noori, Ghazi F.M., Journal of the Chemical Society. Perkin transactions I, 1980, p. 2894 - 2900
  作者：Booth, Brian L.、Noori, Ghazi F.M.

  DOI：——

  日期：——
• v. Auwers; Janssen, Justus Liebigs Annalen der Chemie, 1930, vol. 483, p. 44,57
  作者：v. Auwers、Janssen

  DOI：——

  日期：——
• XLII.—The variation of phenol coefficients in homologous series of phenols
  作者：Charles Edward Coulthard、Joseph Marshall、Frank Lee Pyman

  DOI：10.1039/jr9300000280

  日期：——